Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_cf9ba8e90fa04f838c189d9ee7865ae9 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Pengzhao Shang |e author |
| 700 | 1 | 0 | |a Rui Gao |e author |
| 700 | 1 | 0 | |a Yijia Zhu |e author |
| 700 | 1 | 0 | |a Xiaorui Zhang |e author |
| 700 | 1 | 0 | |a Yang Wang |e author |
| 700 | 1 | 0 | |a Minji Guo |e author |
| 700 | 1 | 0 | |a Hui Peng |e author |
| 700 | 1 | 0 | |a Min Wang |e author |
| 700 | 1 | 0 | |a Juan Zhang |e author |
| 245 | 0 | 0 | |a Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433] |
| 260 | |b Elsevier, |c 2024-06-01T00:00:00Z. | ||
| 500 | |a 2211-3835 | ||
| 500 | |a 10.1016/j.apsb.2024.02.014 | ||
| 546 | |a EN | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Acta Pharmaceutica Sinica B, Vol 14, Iss 6, Pp 2790- (2024) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2211383524000522 | |
| 787 | 0 | |n https://doaj.org/toc/2211-3835 | |
| 856 | 4 | 1 | |u https://doaj.org/article/cf9ba8e90fa04f838c189d9ee7865ae9 |z Connect to this object online. |